191 related articles for article (PubMed ID: 27366865)
1. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models.
Chen Y; Huang H; Yao C; Su F; Guan W; Yan S; Ni Z
Cancer Med; 2016 Sep; 5(9):2477-86. PubMed ID: 27366865
[TBL] [Abstract][Full Text] [Related]
2. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
Si YJ; Guang LX; Yuan FH; Zhang KB
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
[TBL] [Abstract][Full Text] [Related]
3. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells.
Huang Q; Pu P; Xia Z; You Y
J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.
Li LQ; Shen F; Xu XY; Zhang H; Yang XF; Liu WG
ScientificWorldJournal; 2013; 2013():951343. PubMed ID: 23533367
[TBL] [Abstract][Full Text] [Related]
5. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
[TBL] [Abstract][Full Text] [Related]
6. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
9. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
10. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
11. [Ganciclovir induces apoptosis of rat C6 glioma cell transduced with HSV-tk gene].
Ma W; Chen S; Ren Z; Wang W; Zhang J; Su C; Wang R; Li Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):165-9. PubMed ID: 12903520
[TBL] [Abstract][Full Text] [Related]
12. [Suicide gene therapy for glioma using HSV-tk/GCV system].
Xu L; Ge K; Zheng Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
[TBL] [Abstract][Full Text] [Related]
13. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
[TBL] [Abstract][Full Text] [Related]
14. Iron Oxide Nanoparticles Promote Cx43-Overexpression of Mesenchymal Stem Cells for Efficient Suicide Gene Therapy during Glioma Treatment.
Li A; Zhang T; Huang T; Lin R; Mu J; Su Y; Sun H; Jiang X; Wu H; Xu D; Cao H; Sun X; Ling D; Gao J
Theranostics; 2021; 11(17):8254-8269. PubMed ID: 34373740
[No Abstract] [Full Text] [Related]
15. Wild Type p53 gene sensitizes rat C6 glioma cells to HSV-TK/ACV treatment in vitro and in vivo.
Huang Q; Xia Z; You Y; Pu P
Pathol Oncol Res; 2010 Dec; 16(4):509-14. PubMed ID: 20084481
[TBL] [Abstract][Full Text] [Related]
16. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
19. Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.
Ardiani A; Sanchez-Bonilla M; Black ME
Cancer Gene Ther; 2010 Feb; 17(2):86-96. PubMed ID: 19763147
[TBL] [Abstract][Full Text] [Related]
20. Suppression of bladder cancer growth by adeno-associated virus vector-mediated combination of HSV-TK and endostatin in vitro.
Pan JG; Luo RQ; Zhou X; Han RF; Zeng GW
Clin Lab; 2013; 59(9-10):1077-89. PubMed ID: 24273931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
